We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
-3.08%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$307M
AUM Growth
+$41.6M
Cap. Flow
+$61.2M
Cap. Flow %
19.9%
Top 10 Hldgs %
95.94%
Holding
27
New
5
Increased
4
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$30.5M
2
A icon
Agilent Technologies
A
+$27.2M
3
DNA icon
Ginkgo Bioworks
DNA
+$21.1M
4
RVTY icon
Revvity
RVTY
+$19.9M
5
TWST icon
Twist Bioscience
TWST
+$14.3M

Top Sells

Rank Stock Value
1
AMRS
Amyris Inc.
AMRS
+$36.3M
2
NEO icon
NeoGenomics
NEO
+$22.2M
3
ILMN icon
Illumina
ILMN
+$15.7M
4
GH icon
Guardant Health
GH
+$12.3M
5
HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
+$841K

Sector Composition

Rank Sector Weight
1 Healthcare 97.85%
2 Technology 0.88%
3 Financials 0.43%
4 Communication Services 0.27%
5 Consumer Discretionary 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRS
26
DELISTED
Amyris Inc.
AMRS
– –
-2,217,216
Closed -$36.3M
HTGM
27
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
– –
-12,073
Closed -$841K
1
2

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Blue Water Life Science Advisors held 27 positions worth $307M, up 16% from $266M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Blue Water Life Science Advisors deployed $61.2M of net new capital in Q3 2021, opening 5 new positions and adding to 4 existing holdings. Its largest new stake was Agilent Technologies: 168,150 shares worth $26.5M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 84% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NeoGenomics, an estimated $22.2M trimmed.

  • Blue Water Life Science Advisors's largest Q3 2021 buy was Agilent Technologies: 168,150 shares worth $26.5M.
  • Blue Water Life Science Advisors added most to CareDx in Q3 2021, an estimated $30.5M increase.
  • Blue Water Life Science Advisors's biggest Q3 2021 reduction was NeoGenomics, cutting an estimated $22.2M.
  • Blue Water Life Science Advisors fully exited Amyris Inc. in Q3 2021, selling an estimated $36.3M.
  • Blue Water Life Science Advisors's ten largest holdings make up 96% of its $307M portfolio in Q3 2021.
  • Blue Water Life Science Advisors opened 5 new positions and closed 3 in Q3 2021.
  • Blue Water Life Science Advisors's portfolio value rose 16% quarter-over-quarter to $307M.

Based on Blue Water Life Science Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.